At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02627 AB&B BIO-TECH-B
Trading 01-28 10:07:43
50.900
+0.550
+1.09%
High51.300
Low50.000
Vol95.60K
Open50.500
D1 Closing50.350
Amplitude2.58%
Mkt Cap20.00B
Tradable Cap15.08B
Total Shares393.00M
T/O4.82M
T/O Rate0.03%
Tradable Shares296.36M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Sealand Securities Initiates Coverage on AB&B BIO-TECH-B (02627) with "Add" Rating, Highlights Rapid Volume Expansion of Huierkangxin
Riding the Hong Kong Stock Rally: Bull Market Dawns in the East 2026 – 10th Zhitong Finance Capital Markets Annual Conference Invites You to a Capital Feast
Ab&B Bio Tech Co Ltd JS is a China-based company primarily engaged in the research, development, manufacturing, and commercialization of vaccines. Its product pipeline includes two core products, the quadrivalent subunit influenza vaccine and lyophilized human rabies vaccine candidate, along with 11 other vaccine candidates. The Company primarily operates within the domestic market.